Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China · Delayed Price · Currency is CNY 36.04
-0.39 (-1.07%)
Aug 31, 2026, 3:00 PM CST
SHA:600329 Market Cap
SHA:600329 has a market cap or net worth of 24.19 billion as of August 31, 2026. Its market cap has decreased by -20.35% in one year.
Market Cap
24.19B
Enterprise Value
20.75B
Revenue
4.72B
Ranking
n/a
PE Ratio
32.97
Stock Price
36.04
ChartMarket Cap Chart
Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 24.19B, an increase of 249.75%. That is a compound annual growth rate of 5.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 24.19B | -21.42% |
| Dec 31, 2025 | 30.78B | 48.69% |
| Dec 31, 2024 | 20.70B | -6.43% |
| Dec 29, 2023 | 22.12B | 21.24% |
| Dec 30, 2022 | 18.25B | -6.30% |
| Dec 31, 2021 | 19.47B | 73.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dizal (Jiangsu) Pharmaceutical | 27.29B |
| Shijiazhuang Yiling Pharmaceutical | 27.03B |
| Zhejiang Huahai Pharmaceutical | 24.53B |
| Apeloa Pharmaceutical Co.,Ltd | 24.01B |
| Hubei Jumpcan Pharmaceutical | 23.09B |
| Walvax Biotechnology | 22.84B |
| Harbin Pharmaceutical Group | 22.67B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.39B |